New Covid variant BA.2.86: does the UK booster programme go far enough?
Some MPs and experts say criteria for jabs is ‘too narrow’ ahead of ‘rocky ride’ this winter

A “faster-than-planned” rollout of Covid booster vaccines is underway in England amid controversy over denying the shots to healthy adults under 65.
The UK Health Security Agency (UKHSA) began the programme this morning, accelerating its launch over “concerns” about a new Covid variant, said BBC News. There have been 34 confirmed cases of BA.2.86 in England, with 28 of those in one Norfolk care home.
All adults aged 65 and over are eligible, as well as care home residents, frontline health and care workers and those who are clinically at risk, plus their households if aged between 12 and 64. But unlike in 2022, boosters will not be offered to healthy adults aged 50 to 64.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Ministers are facing “urgent calls” to reconsider, said The Guardian. Members of the all-party parliamentary group on coronavirus wrote to the prime minister warning that the NHS could struggle to cope with a winter of high case numbers.
‘Most of us have survived an infection’
Denying under-65s Covid jabs is the right call, given that “almost every one of us has survived one, and most of us have already survived multiple, Covid infections”, Paul Hunter, professor of infectious diseases at the University of East Anglia, told The Guardian.
“Other than doing a population-level vaccination programme, I don’t know what the alternative really is,” said Steve Brine, the Conservative chair of health select committee. The government says it is following the advice of the Joint Committee on Vaccination and Immunisation (JCVI). Brine said he “wouldn’t be making any different decision”.
It’s a different situation to 2020 and 2021, said Susan Hopkins, chief medical adviser at the UKHSA, thanks to varying degrees of immunity from vaccines and infections. Many of those infected experience a “mild, asymptomatic illness and don’t even know they have it”, she told Sky News.
‘Rocky ride’ ahead
The government is “being a bit cavalier and thinking this is just going to be fine”, said the all-party parliamentary group chair, Liberal Democrat MP Layla Moran.
Some MPs believe the JCVI “looked too narrowly” at the criteria by only considering “hospitalisations and deaths”, Jim Reed, BBC health reporter, told Radio 4’s “Today” programme, and not the “wider impact” such as people with infections missing work or school.
Simon Williams, a public health researcher at Swansea University, agreed that extending the booster to over-50s would be a “sensible precaution”. Lawrence Young, a professor of virology at the University of Warwick, said the UK faced a “rocky ride” this winter.
There is “a real case to be made for widening the criteria for who gets a booster”, Devi Sridhar, chair of global public health at the University of Edinburgh, told The Independent. “(We should) make it accessible to those who want to have it.”
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Chas Newkey-Burden has been part of The Week Digital team for more than a decade and a journalist for 25 years, starting out on the irreverent football weekly 90 Minutes, before moving to lifestyle magazines Loaded and Attitude. He was a columnist for The Big Issue and landed a world exclusive with David Beckham that became the weekly magazine’s bestselling issue. He now writes regularly for The Guardian, The Telegraph, The Independent, Metro, FourFourTwo and the i new site. He is also the author of a number of non-fiction books.
-
The micro-cheating phenomenon
In The Spotlight Relationship buzzword covers a host of 'seemingly small betrayals'
By Chas Newkey-Burden, The Week UK Published
-
Why did Donald Trump U-turn on tariffs?
Today's Big Question President's 'easy-win' trade war couldn't survive the realities of the US economy
By Jamie Timson, The Week UK Published
-
Manhunt: a 'shattering' study of the life and death of Raoul Moat
The Week Recommends Robert Icke's new production is a 'visceral' exploration of male violence
By Irenie Forshaw, The Week UK Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
New Alzheimer's drug rejected: is Nice being nasty?
Talking Point Health watchdog has announced lecanemab will be denied to NHS patients on cost grounds
By The Week UK Published
-
Israel, UN agree to Gaza pauses for polio vaccinations
Speed Read Gaza's first case of polio in 25 years was confirmed last week in a 10-month-old boy who is now partially paralyzed
By Rafi Schwartz, The Week US Published
-
WHO declares mpox a global health emergency
Speed Read An outbreak of the viral disease formerly known as monkeypox continues to spread in Africa
By Rafi Schwartz, The Week US Published
-
Have we defeated malaria?
The Explainer Roll-out of low-cost vaccine means a world free from disease that claims 600,000 lives a year 'finally within sight'
By The Week UK Published
-
Roll-out of affordable malaria vaccine begins
Speed Read R21 is approved for babies and may save hundreds of thousands of lives
By Arion McNicoll, The Week UK Published